SCHEMBL17832304

SCHEMBL17832304

O=Cc1ccc(N2CCC(O)(c3ccc(OC(F)(F)F)cc3)CC2)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 2/20 0.42
CCR1 P32246 1/20 0.42
MCHR1 Q99705 3/20 0.41
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
BACE1 P56817 1/20 0.41
CACNA1G O43497 1/20 0.41
CACNA1H O95180 1/20 0.41
CACNA1I Q9P0X4 1/20 0.41
AR P10275 2/20 0.40
SMO Q99835 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
LCAT P04180 1/20 0.39
KCNH2 Q12809 1/20 0.39
SCD O00767 1/20 0.38
SCN9A Q15858 2/20 0.38
SIGMAR1 Q99720 1/20 0.38
AURKA O14965 1/20 0.37
RPS6KB1 P23443 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17832207 0.87 MCHR1 (0.46) CCR1MCHR1MEN1KMT2ASIGMAR1
SCHEMBL17832320 0.85 CHRM4 (0.41) CHRM4MCHR1BCHEACHEBACE1
SCHEMBL17832321 0.84 SCD (0.52) CHRM4BCHEACHEBACE1CACNA1G
SCHEMBL17832253 0.82 CACNA1G (0.38) CHRM4BCHEACHEBACE1CACNA1G
SCHEMBL17832319 0.82 BCHE (0.44) MCHR1BCHEACHEBACE1CACNA1G
SCHEMBL17832244 0.78 LCAT (0.44) CHRM4BCHEACHEBACE1CACNA1G
SCHEMBL17832235 0.78 FAAH (0.47) CHRM4KCNH2
SCHEMBL17832273 0.74 CACNA1B (0.40) BCHEACHEBACE1CACNA1GCACNA1H
SCHEMBL17832250 0.74 ACACB (0.51)
SCHEMBL25082374 0.73 KCNJ1 (0.44) CACNA1GCACNA1HCACNA1ISCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334927-A1 Nitroimidazole Compound, Preparation Method Therefor And Use Thereof In Drug Manufacturing SHANGHAI SUN-SAIL PHARMACEUTICAL SCIENCE & TECHNOLOGY CO., LTD. (CN) 2017-11-23 US disclosed
US-20170334927-A1 Nitroimidazole Compound, Preparation Method Therefor And Use Thereof In Drug Manufacturing SHANGHAI SUN-SAIL PHARMACEUTICAL SCIENCE & TECHNOLOGY CO., LTD. (CN) 2017-11-23 US disclosed
WO-2016091207-A1 NITROMIDAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN DRUG MANUFACTURING 上海阳帆医药科技有限公司 2016-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334927-A1 Nitroimidazole Compound, Preparation Method Therefor And Use Thereof In Drug Manufacturing NISCH, CYP51A1, CYP4F11 CHRM4 4724/4885CCR1 4700/4885MCHR1 4474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.